Exploration of factors that influence relative and absolute uptake of LAIV could be useful to inform influenza vaccination programs and future policy regarding preferential use of vaccine formulations. Our results indicate increasing use of LAIV among younger children in the United States, demonstrating broad acceptability of the formulation.